VectivBio

-$0.40 (-6.44%) Today
+$0.01 (+0.17%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VectivBio and other ETFs, options, and stocks.

About VECT

VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the development of treatments for severe rare conditions with significant unmet medical need. Its product pipeline include Apraglutide and CoMet.

CEO
Luca Santarelli
Employees
32
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
2019

VECT Key Statistics

Market cap
208.44M
Price-Earnings ratio
—
Dividend yield
—
Average volume
26.92K
High today
$6.28
Low today
$5.63
Open price
$6.28
Volume
7.77K
52 Week high
$16.75
52 Week low
$2.74

VECT Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 26, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure